NYSE:PRGO

Perrigo is a leading provider of affordable and reliable over-the-counter health and wellness solutions to prevent and treat self-managed conditions such as cold and cough, pain relief, gastrointestinal, personal care, infant nutrition, prescription, oral care, etc. With a history of 130 years, the company has developed rich expertise in delivering effective solutions to its customers who trust Perrigo for its quality and products. Bronchenolo, Ibuprofen, and Nicotine Polacrilex tablets are a few of Perrigo’s leading products. The company provides both private label and branded self-care products in North American, European and other markets. The Americas account for ~60% of the company’s total revenues. Perrigo’s superior manufacturing and scale and excellent customer service positions it well to benefit from a growing aging population and growing OTC category sales trends. The company is reconfiguring its portfolio to become a focused consumer self-care company and is also divesting its Rx and Animal health business in this regard. The New Perrigo is poised to become a $3.7 billion global consumer company.